Welcome to our dedicated page for Atmofizer Techno news (Ticker: ATMFF), a resource for investors and traders seeking the latest updates and insights on Atmofizer Techno stock.
Atmofizer Technologies Inc. reports company developments tied to air treatment technology, public-company capital actions and corporate agreements. The company’s consumer and industrial solutions are based on patent-protected and patent-pending ultrafine particle agglomeration and neutralization technology used in A500 air purifiers and under development for HVAC-integrated applications.
Recurring news themes include business updates, interim and annual financial results, patent activity covering ultra-fine particle aggregation, neutralization and filtration, share consolidation activity, at-the-market equity program disclosures, and material agreement updates. Company communications also address air quality topics connected to wildfire smoke, nano-scale particles, viruses and bacteria.
Atmofizer Technologies Inc. (CSE: ATMO; OTCQB: ATMFF) has announced significant advancements with its agglomeration technology, which effectively reduces ultrafine nanoparticle counts by 44% at a rate of 1.4 liters per minute. This patented method enhances air quality by allowing for safer neutralization of harmful particles. Additionally, Atmofizer has opened a new R&D lab in Toronto aimed at innovating HVAC systems and further testing their technology in practical settings. This initiative could lead to new partnerships and markets if successful.
Atmofizer Technologies Inc. (OTCQB: ATMFF) reported financial results for the year ending December 31, 2021, revealing a revenue of $497,280 and a net loss of $21.43 million, compared to a loss of $1.17 million in 2020. The notable increase in expenses, totaling $13.18 million, was primarily due to operational expansion and a listing expense of $7.09 million linked to a reverse takeover. Despite a gross profit of $83,199 (16.7%), overall financial performance raised concerns among investors, driven by significant net losses and high operational costs.
Atmofizer Technologies has established an internal R&D lab in Toronto to advance its nanoparticle agglomeration technology for HVAC systems. The innovative technology aims to enhance air quality by increasing particle sizes for better filtration, which can lower energy costs and extend filter life. Recent tests indicate a 44% reduction in ultrafine particle counts, potentially benefiting residential and commercial HVAC systems. Atmofizer has delivered around 2,000 agglomeration engines globally and anticipates further demand from various sectors, including maritime and aviation.
Atmofizer Technologies Inc. has announced the issuance of a key patent from the USPTO for its air and water purification technology, titled Ultra-Fine Particle Aggregation, Neutralization and Filtration. This patent not only protects their intellectual property but also validates their approach to improving indoor air quality, especially in light of COVID-19. Furthermore, Atmofizer has entered into a Debt Settlement Agreement, issuing 2,500,000 shares at $0.09 each to settle $225,000 in debt. This strategic move is aimed at enhancing their market position as leaders in air purification technology.
Atmofizer Technologies Inc. (CSE: ATMO, OTCQB: ATMFF) has launched an internal R&D lab in Toronto to innovate HVAC systems using its nanoparticle agglomeration technology. This technology aims to enhance air quality and reduce energy costs by increasing the size of harmful particles, making them easier to neutralize with UV light and conventional filters. Initial tests show a 44% reduction in ultrafine particles, potentially leading to lower operational costs and improved filter efficiency, thereby benefiting both consumers and the environment.
Atmofizer Technologies Inc. has introduced a patented air and water purification technology aimed at combating airborne viruses and pollution. The system utilizes a unique method of agglomeration to cluster nano-scale particles, making them easier to neutralize. This innovation is timely, given the increased focus on air quality post-COVID-19. The company plans to license its technology to various industries, enhancing air safety and reducing operational costs. Independent data supports its efficacy in reducing harmful particles.
Atmofizer Technologies Inc. announced that the USPTO issued a notice of allowance for its air and water purification technology patent, US Patent Application No. 17/471,610. This patent provides broad protection for Atmofizer's innovative technology aimed at purifying ultra-fine particles, enhancing air quality, and potentially disrupting the air treatment market. CEO Olivier Centner highlighted the importance of this patent in addressing air safety amid growing market demand. The patent is expected to be officially issued soon, providing a strategic advantage for Atmofizer's commercialization efforts.